• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding the links between cardiovascular disease and Parkinson's disease.了解心血管疾病与帕金森病之间的联系。
Mov Disord. 2020 Jan;35(1):55-74. doi: 10.1002/mds.27836. Epub 2019 Sep 4.
2
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.他汀类药物在近期发病且血管风险增加的帕金森病患者中使用不足:来自英国帕金森病追踪研究和牛津帕金森病中心(OPDC)发现队列的结果。
J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1183-1190. doi: 10.1136/jnnp-2016-313642. Epub 2016 Sep 26.
3
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.血管、炎症和代谢危险因素与 2 型糖尿病帕金森病患者痴呆的关系。
Aging (Albany NY). 2020 Aug 15;12(15):15682-15704. doi: 10.18632/aging.103776.
4
Are Parkinson's Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study.帕金森病患者是否更容易受到心血管风险影响:一项神经影像学和神经心理学研究
J Int Neuropsychol Soc. 2017 Apr;23(4):322-331. doi: 10.1017/S1355617717000017. Epub 2017 Feb 6.
5
The Impact of Type 2 Diabetes in Parkinson's Disease.2 型糖尿病对帕金森病的影响。
Mov Disord. 2022 Aug;37(8):1612-1623. doi: 10.1002/mds.29122. Epub 2022 Jun 14.
6
Association between physical fitness, cardiovascular risk factors, and Parkinson's disease.体能与心血管危险因素和帕金森病的关联。
Eur J Prev Cardiol. 2018 Sep;25(13):1409-1415. doi: 10.1177/2047487318771168. Epub 2018 Apr 18.
7
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).帕金森病队列研究(DeNoPa)中帕金森病确诊后 4 年进展的基线预测因子。
Mov Disord. 2019 Jan;34(1):67-77. doi: 10.1002/mds.27492. Epub 2018 Nov 23.
8
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.希腊环境因素与不同帕金森病亚型的关系:希腊帕金森病生物银行数据分析。
Parkinsonism Relat Disord. 2019 Oct;67:105-112. doi: 10.1016/j.parkreldis.2019.08.013. Epub 2019 Aug 26.
9
Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson's Disease.营养、生活方式和代谢危险因素对帕金森病的贡献。
Mov Disord. 2024 Jul;39(7):1203-1212. doi: 10.1002/mds.29778. Epub 2024 Mar 26.
10
Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.老年人痛风与帕金森病风险:一项基于美国医疗保险数据的研究
BMC Neurol. 2019 Jan 5;19(1):4. doi: 10.1186/s12883-018-1234-x.

引用本文的文献

1
Nature's Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson's Disease.大自然的疗法:探索蜂胶缓解帕金森病非运动症状的潜力。
Molecules. 2025 Apr 8;30(8):1672. doi: 10.3390/molecules30081672.
2
Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons.解读肠道-器官轴中的氧化三甲胺:从生物标志物、细胞死亡机制到治疗前景
Drug Des Devel Ther. 2025 Apr 29;19:3363-3393. doi: 10.2147/DDDT.S512207. eCollection 2025.
3
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.合并症及其对帕金森病的影响:当前证据的叙述性概述
Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942.
4
Cardiovascular health and its association with dementia, Parkinson's Disease, and mortality among UK older adults.英国老年人的心血管健康及其与痴呆症、帕金森病和死亡率的关联。
Brain Behav Immun Health. 2025 Mar 27;45:100986. doi: 10.1016/j.bbih.2025.100986. eCollection 2025 May.
5
Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study.巴西帕金森病的患病率、分布及未来预测:来自巴西ELSI队列研究的见解
Lancet Reg Health Am. 2025 Mar 28;44:101046. doi: 10.1016/j.lana.2025.101046. eCollection 2025 Apr.
6
Association between life's essential 8 and Parkinson's disease: a case-control study.生命必需的八项指标与帕金森病之间的关联:一项病例对照研究。
BMC Public Health. 2025 Feb 1;25(1):411. doi: 10.1186/s12889-025-21648-0.
7
Associations Between Diabetes Mellitus and Neurodegenerative Diseases.糖尿病与神经退行性疾病之间的关联。
Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.
8
Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis.美国帕金森病患者心血管疾病所致死亡率的趋势:一项回顾性分析。
Clin Cardiol. 2025 Jan;48(1):e70079. doi: 10.1002/clc.70079.
9
Associations of motor and neuropsychiatric symptoms with comorbidities in prodromal Parkinson's disease.前驱期帕金森病中运动和神经精神症状与合并症的关联。
Front Aging Neurosci. 2024 Nov 25;16:1452766. doi: 10.3389/fnagi.2024.1452766. eCollection 2024.
10
Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications.血栓形成在神经退行性疾病中的作用:神经血管并发症的复杂机制
Mol Neurobiol. 2025 Apr;62(4):4802-4836. doi: 10.1007/s12035-024-04589-4. Epub 2024 Nov 1.

本文引用的文献

1
Low Vitamin B12 and Parkinson Disease: Potential Link to Reduced Cholinergic Transmission and Severity of Disease.低维生素B12与帕金森病:与胆碱能传递减少及疾病严重程度的潜在关联。
Mayo Clin Proc. 2019 May;94(5):757-762. doi: 10.1016/j.mayocp.2019.01.039.
2
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.帕金森病中的自身免疫:α-突触核蛋白特异性 T 细胞的作用。
Front Immunol. 2019 Feb 25;10:303. doi: 10.3389/fimmu.2019.00303. eCollection 2019.
3
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease.帕金森病中 SMPD1 突变、活性和 α-突触核蛋白积累。
Mov Disord. 2019 Apr;34(4):526-535. doi: 10.1002/mds.27642. Epub 2019 Feb 20.
4
Brain cholesterol metabolism and Parkinson's disease.脑胆固醇代谢与帕金森病。
Mov Disord. 2019 Mar;34(3):386-395. doi: 10.1002/mds.27609. Epub 2019 Jan 25.
5
Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials.地中海饮食、心血管疾病和糖尿病患者的死亡率:前瞻性队列研究和随机临床试验的系统评价和荟萃分析。
Crit Rev Food Sci Nutr. 2020;60(7):1207-1227. doi: 10.1080/10408398.2019.1565281. Epub 2019 Jan 24.
6
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial.神经衍生外泌体在帕金森病患者运动功能相关分子机制研究中的效用:依西那肽-PD 试验的二次分析。
JAMA Neurol. 2019 Apr 1;76(4):420-429. doi: 10.1001/jamaneurol.2018.4304.
7
Overview the effect of statin therapy on dementia risk, cognitive changes and its pathologic change: a systematic review and meta-analysis.他汀类药物治疗对痴呆风险、认知变化及其病理改变的影响概述:一项系统评价和荟萃分析
Ann Transl Med. 2018 Nov;6(22):435. doi: 10.21037/atm.2018.06.43.
8
Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism.鞘脂类在帕金森病和帕金森综合征发病机制中的作用。
Trends Endocrinol Metab. 2019 Feb;30(2):106-117. doi: 10.1016/j.tem.2018.11.003. Epub 2018 Dec 6.
9
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).帕金森病队列研究(DeNoPa)中帕金森病确诊后 4 年进展的基线预测因子。
Mov Disord. 2019 Jan;34(1):67-77. doi: 10.1002/mds.27492. Epub 2018 Nov 23.
10
Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.小血管疾病对帕金森病运动和认知障碍严重程度的影响。
J Clin Neurosci. 2018 Dec;58:70-74. doi: 10.1016/j.jocn.2018.10.029. Epub 2018 Oct 14.

了解心血管疾病与帕金森病之间的联系。

Understanding the links between cardiovascular disease and Parkinson's disease.

机构信息

The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.

Translational Brain Research Center and Department of Neurology, Penn State College of Medicine, Hershey, Pennsylvania, USA.

出版信息

Mov Disord. 2020 Jan;35(1):55-74. doi: 10.1002/mds.27836. Epub 2019 Sep 4.

DOI:10.1002/mds.27836
PMID:31483535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6981000/
Abstract

Studies investigating the associations between genetic or environmental factors and Parkinson's disease (PD) have uncovered a number of factors shared with cardiovascular disease, either as risk factors or manifestations of cardiovascular disease itself. Older age, male sex, and possibly type 2 diabetes are examples. On the other hand, coffee consumption and physical activity are each associated with a lower risk of both PD and cardiovascular disease. This observation raises questions about the underlying pathophysiological links between cardiovascular disease and PD. There is evidence for common mechanisms in the areas of glucose metabolism, cellular stress, lipid metabolism, and inflammation. On the other hand, smoking and total/low-density lipoprotein cholesterol appear to have opposite associations with cardiovascular disease and PD. Thus, it is uncertain whether the treatment of cardiovascular risk factors will impact on the onset or progression of PD. The available data suggest that a nuanced approach is necessary to manage risk factors such as cholesterol levels once the associations are better understood. Ultimately, the choice of therapy may be tailored to a patient's comorbidity profile. This review presents the epidemiological evidence for both concordant and discordant associations between cardiovascular disease and PD, discusses the cellular and metabolic processes that may underlie these links, and explores the implications this has for patient care and future research. © 2019 International Parkinson and Movement Disorder Society.

摘要

研究调查了遗传或环境因素与帕金森病(PD)之间的关联,发现了一些与心血管疾病相关的因素,这些因素既是心血管疾病的风险因素,也是心血管疾病本身的表现。例如,年龄较大、男性以及可能的 2 型糖尿病。另一方面,咖啡的摄入和体育活动与 PD 和心血管疾病的风险降低均相关。这一观察结果引发了关于心血管疾病和 PD 之间潜在病理生理联系的问题。在葡萄糖代谢、细胞应激、脂质代谢和炎症等领域存在共同的机制证据。另一方面,吸烟和总/低密度脂蛋白胆固醇似乎与心血管疾病和 PD 呈相反的关联。因此,尚不确定治疗心血管危险因素是否会影响 PD 的发病或进展。现有数据表明,一旦更好地了解这些关联,就需要采取细致的方法来管理胆固醇水平等危险因素。最终,治疗方案的选择可能需要根据患者的合并症情况进行定制。本综述介绍了心血管疾病与 PD 之间一致和不一致关联的流行病学证据,讨论了可能构成这些关联的细胞和代谢过程,并探讨了这对患者护理和未来研究的影响。© 2019 国际帕金森病和运动障碍协会。